| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2009 | CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/24/2009 | CA2390563C Apparatus and method for preparing microparticles using in-line solvent extraction |
| 02/24/2009 | CA2373962C Immediate release medicinal compositions for oral use |
| 02/24/2009 | CA2362888C Use of r-aryl propionic acids for producing medicaments to treat diseases in humans and animals, whereby said diseases can be therapeutically influenced by inhibiting the activation of nf-kb |
| 02/24/2009 | CA2362601C Deep penetrating antimicrobial compositions |
| 02/24/2009 | CA2356912C Pharmaceutical compositions for the treatment of ocular hypertension or glaucoma |
| 02/24/2009 | CA2356151C Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 02/24/2009 | CA2355888C Blood pool agents for nuclear magnetic resonance diagnostics |
| 02/24/2009 | CA2354472C Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2339597C Anti-inflammatory analgesic preparations comprising 3-o-ascorbic acid derivatives |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2334568C Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2297406C Tricyclic vasopressin agonists |
| 02/24/2009 | CA2264238C Galenic formula with extended release of milnacipran |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/24/2009 | CA2225416C A triazolylmethyl-indole ethylamine bisulfate salt |
| 02/24/2009 | CA2224438C Vinyl-pyrrolidinone cephalosporins with basic substituents |
| 02/24/2009 | CA2219455C Use of pyrrolidine derivatives for treating alcoholism |
| 02/24/2009 | CA2194236C Helicobacter proteins and vaccines |
| 02/24/2009 | CA2188043C 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/23/2009 | CA2716082A1 Process for preparing concentrated aqueous micellar solutions |
| 02/23/2009 | CA2639780A1 Zwitterionic compounds and use thereof |
| 02/22/2009 | CA2639779A1 Algae essence nucleic acid fluid concentration preparation method |
| 02/21/2009 | CA2638999A1 Sore throat relief composition and method of producing the same |
| 02/21/2009 | CA2638970A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/21/2009 | CA2638969A1 Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 02/21/2009 | CA2638952A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/19/2009 | WO2009023877A2 Formulations for treatment of ocular diseases or conditions |
| 02/19/2009 | WO2009023876A1 Method of treating non-small cell lung cancer |
| 02/19/2009 | WO2009023854A1 Bicyclic sphingosine 1-phosphate analogs |
| 02/19/2009 | WO2009023846A2 Methods for heat shock protein dependent cancer treatment |
| 02/19/2009 | WO2009023844A2 3' substituted compounds having 5-ht6 receptor affinity |
| 02/19/2009 | WO2009023820A1 Improving the tolerability of a serotonin antagonist and a nsri, a snri or a rima by using them in combination |
| 02/19/2009 | WO2009023819A2 Toll like receptor modulators |
| 02/19/2009 | WO2009023773A2 Galactokinase inhibitors |
| 02/19/2009 | WO2009023765A1 Non-textile polymer compositions and methods |
| 02/19/2009 | WO2009023761A2 Pharmaceutical compositions comprising ropinirole |
| 02/19/2009 | WO2009023758A1 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
| 02/19/2009 | WO2009023757A1 Therapeutic compounds |
| 02/19/2009 | WO2009023754A1 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 02/19/2009 | WO2009023752A1 Adrenergic compounds |
| 02/19/2009 | WO2009023707A1 Method of treating disease involving myelin and/or axonal loss |
| 02/19/2009 | WO2009023677A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| 02/19/2009 | WO2009023669A1 Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof |
| 02/19/2009 | WO2009023664A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | WO2009023655A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | WO2009023631A1 Anti-inflammatory compounds and uses thereof |
| 02/19/2009 | WO2009023620A2 Compositions with perfluorinated ingredients |
| 02/19/2009 | WO2009023567A1 Quaternary opioid carboxamides |
| 02/19/2009 | WO2009023544A2 Dosage unit anion-exchange polymer pharmaceutical compositions |
| 02/19/2009 | WO2009023539A2 Tetrahydropyridine carboxamide derivatives as trpvl antagonists |
| 02/19/2009 | WO2009023509A2 Therapeutic combinations useful in treating cftr related diseases |
| 02/19/2009 | WO2009023495A2 Bisubstrate inhibitors of adenylosuccinate synthetase |
| 02/19/2009 | WO2009023487A1 Tetracyclic compounds for the treatment of hepatitis c |
| 02/19/2009 | WO2009023473A2 Antimicrobial parenteral formulation |
| 02/19/2009 | WO2009023471A2 Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation |
| 02/19/2009 | WO2009023453A1 Azepine derivatives as gamma-secretase inhibitors |
| 02/19/2009 | WO2009023434A2 Method for stabilizing phenylephrine |
| 02/19/2009 | WO2009023416A2 Cosmetic methods and compositions for repairing human skin |
| 02/19/2009 | WO2009023402A2 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | WO2009023357A2 Curcumin derivatives and their use as radioprotectors |
| 02/19/2009 | WO2009023299A2 Anti-angiogenic agents and methods of use |
| 02/19/2009 | WO2009023292A1 Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| 02/19/2009 | WO2009023272A1 Heterocyclic inhibitors of necroptosis |
| 02/19/2009 | WO2009023269A2 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 02/19/2009 | WO2009023267A2 Methods for modulating development and expansion of il-17 expressing cells |
| 02/19/2009 | WO2009023253A2 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| 02/19/2009 | WO2009023233A1 Substituted oxazolidinone derivatives |
| 02/19/2009 | WO2009023232A1 Novel forms of cddo methyl ester |
| 02/19/2009 | WO2009023211A1 Triazole compounds that modulate hsp90 activity |
| 02/19/2009 | WO2009023207A1 Thiazolium compounds for treating gastrointestinal complications |
| 02/19/2009 | WO2009023201A1 Rigid derivatives of triptolide as anticancer, immune suppressant, anti-fibrosis, and cns protectant agents |
| 02/19/2009 | WO2009023196A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 02/19/2009 | WO2009023181A1 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 02/19/2009 | WO2009023180A1 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 02/19/2009 | WO2009023179A2 Nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | WO2009023177A1 Polymer therapy for the treatment of chronic microvascular diseases |
| 02/19/2009 | WO2009023160A2 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 02/19/2009 | WO2009023126A2 Bicyclic amides for enhancing glutamatergic synaptic responses |
| 02/19/2009 | WO2009023123A1 Novel laulimalide analogues as therapeutic agents |
| 02/19/2009 | WO2009023122A1 Cobalamin regimens for the treatment of nitrogen oxide-mediated conditions |
| 02/19/2009 | WO2009023059A2 Treatment of viral infections by modulation of host cell metabolic pathways |
| 02/19/2009 | WO2009023053A2 Use of rsk inhibitors to impede intracellular pathogen infections |
| 02/19/2009 | WO2009023030A1 Immediate release and sustained release ibuprofen dosing regimen |
| 02/19/2009 | WO2009023025A1 Methods for treatment and prevention of ototoxicity by sirna |
| 02/19/2009 | WO2009023014A1 Emamectin compositions and methods |
| 02/19/2009 | WO2009023013A1 Praziquantel and cmetidine compositions and methods |
| 02/19/2009 | WO2009022961A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/19/2009 | WO2009022934A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 02/19/2009 | WO2009022933A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
| 02/19/2009 | WO2009022932A1 Pharmaceutical compositions comprising monocholine succinate salts |
| 02/19/2009 | WO2009022899A1 Gel containing pirfenidone |
| 02/19/2009 | WO2009022898A1 A composition based on perhydrosqualene and collagen-polyvinylpyrrolidone for filling minor cutaneous depressions |
| 02/19/2009 | WO2009022894A1 Pharmaceutical composition combining an antiandrogenic agent, a synthetic steroidal estrogenic agent and vitamin agents, which can be used to control and treat late-onset female acne |
| 02/19/2009 | WO2009022893A1 Pharmaceutical composition combining an antimicrobial agent and a selective enkephalinase enzyme inhibitor, which can be used to control and treat acute bacterial diarrhoea |